Spirepoint Private Client’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,000	Closed	-$238K	–	225
2024 Q3	$238K	Sell	2,000 -114	-5%	-$13.6K	0.03%	189
2024 Q2	$302K	Hold	2,114	–	–	0.04%	174
2024 Q1	$271K	Buy	+2,114	New	+$271K	0.04%	172